Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Thasler WE"" wg kryterium: Autor


Tytuł:
Bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro.
Autorzy:
Kersten V; Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, D-91054 Erlangen, Germany.
Seitz T; Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, D-91054 Erlangen, Germany.
Sommer J; Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, D-91054 Erlangen, Germany.
Thasler WE; Human Tissue and Cell Research-Services GmbH, Am Klopferspitz 19, D-82152 Planegg, Germany.
Bosserhoff A; Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, D-91054 Erlangen, Germany.
Hellerbrand C; Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, D-91054 Erlangen, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 04; Vol. 24 (13). Date of Electronic Publication: 2023 Jul 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/metabolism
Humans ; Cell Line, Tumor ; Hepatic Stellate Cells/metabolism ; Bone Morphogenetic Proteins/metabolism ; Cell Proliferation
Czasopismo naukowe
Tytuł:
Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche.
Autorzy:
Seitz T; Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany.
John N; Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany.
Sommer J; Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany.
Dietrich P; Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany.
Thasler WE; Hepacult GmbH, Martinsried, D-82152 Planegg, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, D-91054 Erlangen, Germany.
Evert K; Institute of Pathology, University of Regensburg, D-93053 Regensburg, Germany.
Lang SA; Department of General, Visceral and Transplantation Surgery, University Hospital Rheinisch-Westfälisch Technische Hochschule Aachen, D-52074 Aachen, Germany.
Bosserhoff A; Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, D-91054 Erlangen, Germany.
Hellerbrand C; Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, D-91054 Erlangen, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 29; Vol. 23 (19). Date of Electronic Publication: 2022 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/metabolism
Uveal Neoplasms*/metabolism
Cell Proliferation ; Culture Media, Conditioned/metabolism ; Culture Media, Conditioned/pharmacology ; Fibroblast Growth Factors/metabolism ; Hepatic Stellate Cells/metabolism ; Humans ; Melanoma ; Phenylurea Compounds ; Pyrimidines
SCR Disease Name:
Uveal melanoma
Czasopismo naukowe
Tytuł:
Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma.
Autorzy:
Fritz V; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Malek L; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Gaza A; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, 91054 Erlangen, Germany.
Wormser L; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Appel M; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Kremer AE; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, 91054 Erlangen, Germany.
Thasler WE; Department of General and Visceral Surgery, Red Cross Hospital of Munich, 80634 Munich, Germany.
Siebler J; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, 91054 Erlangen, Germany.
Neurath MF; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, 91054 Erlangen, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, 91054 Erlangen, Germany.
Hellerbrand C; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Bosserhoff AK; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, 91054 Erlangen, Germany.
Dietrich P; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, 91054 Erlangen, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Mar 09; Vol. 13 (5). Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells.
Autorzy:
Seitz T; Institute of Biochemistry (Emil-Fischer-Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Department of Internal Medicine I, University Hospital Regensburg, D-93053 Regensburg, Germany.
Hackl C; Department of Surgery, University Hospital Regensburg, D-93053 Regensburg, Germany.
Freese K; Institute of Biochemistry (Emil-Fischer-Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, D-91054 Erlangen, Germany.
Dietrich P; Institute of Biochemistry (Emil-Fischer-Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Medical Clinic 1, Department of Medicine, University Hospital Erlangen, Friedrich-Alexander-University, D-91054 Erlangen, Germany.
Mahli A; Institute of Biochemistry (Emil-Fischer-Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, D-91054 Erlangen, Germany.
Thasler RM; Stiftung HTCR, BioPark III, Am BioPark 13, D-93053 Regensburg, Germany.
Thasler WE; Hepacult GmbH, D-82152 Martinsried, Germany.
Lang SA; Department of Surgery and Transplantation, University Hospital RWTH Aachen, D-52074 Aachen, Germany.
Bosserhoff AK; Institute of Biochemistry (Emil-Fischer-Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, D-91054 Erlangen, Germany.
Hellerbrand C; Institute of Biochemistry (Emil-Fischer-Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, D-91054 Erlangen, Germany.; Department of Internal Medicine I, University Hospital Regensburg, D-93053 Regensburg, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, D-91054 Erlangen, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jan 29; Vol. 13 (3). Date of Electronic Publication: 2021 Jan 29.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Prognostic Impact of Pedicle Clamping during Liver Resection for Colorectal Metastases.
Autorzy:
Schiergens TS; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Drefs M; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Dörsch M; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Kühn F; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Albertsmeier M; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Niess H; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Schoenberg MB; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Assenmacher M; Department of Statistics, Ludwig-Maximilians-University Munich, Akademiestr 1, D-80799 Munich, Germany.
Küchenhoff H; Department of Statistics, Ludwig-Maximilians-University Munich, Akademiestr 1, D-80799 Munich, Germany.
Thasler WE; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Guba MO; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Angele MK; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Rentsch M; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Werner J; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Andrassy J; Department of General, Visceral and Transplant Surgery, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Dec 29; Vol. 13 (1). Date of Electronic Publication: 2020 Dec 29.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma.
Autorzy:
Seitz T; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Freese K; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Dietrich P; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.; Medical Clinic 1, Department of Medicine, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen, Germany.
Thasler WE; Hepacult GmbH, Planegg/Martinsried, Germany.
Bosserhoff A; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany.
Hellerbrand C; Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany. .; Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Mar 11; Vol. 10 (1), pp. 4546. Date of Electronic Publication: 2020 Mar 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Carcinoma, Hepatocellular/*pathology
Fibroblast Growth Factor 9/*metabolism
Hepatic Stellate Cells/*pathology
Liver Neoplasms/*pathology
Acrylamides/pharmacology ; Apoptosis ; Biomarkers, Tumor/genetics ; Carcinoma, Hepatocellular/drug therapy ; Carcinoma, Hepatocellular/metabolism ; Cell Movement ; Cell Proliferation ; Fibroblast Growth Factor 9/genetics ; Hepatic Stellate Cells/drug effects ; Hepatic Stellate Cells/metabolism ; Humans ; Liver Neoplasms/drug therapy ; Liver Neoplasms/metabolism ; Prognosis ; Quinazolines/pharmacology ; Receptor, Fibroblast Growth Factor, Type 4/antagonists & inhibitors ; Receptor, Fibroblast Growth Factor, Type 4/metabolism ; Survival Rate ; Tumor Cells, Cultured
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies